Our June medtech 2020 edition is now live. We explore recent deal and financing trends in the medtech field and showcase a number of companies developing innovations and looking to seek industry partners.
InVivo Therapeutics is developing a resorbable biomaterial scaffold, the investigational Neuro-Spinal Scaffold, to treat patients with spinal cord injury (SCI). The Neuro-Spinal Scaffold is in clinical trials for acute SCI, and InVivo is searching for synergistic pipeline expansion opportunities.
Cancer Genetics, Inc., a global leader in technology-driven drug discovery and preclinical services, delivers custom solutions for biotech and pharma companies worldwide developing advanced therapies in precision medicine.
Accelerating the drug discovery and development process, Bioelectronica has developed Hypercell, a digital biochemistry integrated single-cell identification and sorting system offering superior output.
Semi-virtual SELMA Diagnostics is harnessing its SELMA technology to identify changes in circulating DNA taken from blood samples to create diagnostic tests for early cancer detection, diagnosis and treatment.
Engine Biosciences has developed a multi-layered platform, NetMAPPR, which integrates machine learning and combinatorial CRISPR to decode biological networks, pinpoint crucial units, and design specific therapeutics.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.